What this study is
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
What's being tested
- Patients undergoing endoscopic ultrasound procedures
Intervention · DEVICE
Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.
Study details
- Sponsor
- Orlando Health, Inc.
- Conditions
- Pancreatic Cancer · Pancreas Disease · Pancreatic Cyst
- Enrolling
- 310 people
- Starts
- 2024-01-19
- Est. completion
- 2027-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 100 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥ 18 years
- Any patient undergoing endoscopic ultrasound examination
You can't join if
- Age < 18 years
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openOrlando Health
Orlando, Florida, United States
- Shyam Varadarajulu, MD · Contact321-841-2431shyam.varadarajulu@orlandohealth.com
- Barbara Broome · Contact321-841-4356barbara.broome@orlandohealth.com
Recruiting
Study team
Sponsor
Orlando Health, Inc.
Study ID 24.015.01
Principal investigator
Shyam Varadarajulu, MD
Orlando Health, Digestive Health Institute
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.